Indication
Primary hyperoxaluria type I
Primary hyperoxaluria type I is a rare autosomal recessive metabolic disorder caused by pathogenic variants in the *AGXT* gene, leading to a deficiency of the hepatic peroxisomal enzyme alanine:glyoxylate aminotransferase. Read more about Primary hyperoxaluria type I
3 drugs 2 manufacturers
Drugs that treat it
Common Primary hyperoxaluria type I therapies.
RIVFLOZA (nedosiran sodium)
RIVFLOZA (nedosiran sodium)
News & literature
Coming soonRelated codes
Coming soonRelated conditions & guidelines
Coming soonPrimary hyperoxaluria type I is a rare autosomal recessive metabolic disorder caused by pathogenic variants in the *AGXT* gene, leading to a deficiency of the hepatic peroxisomal enzyme alanine:glyoxylate aminotransferase.
This enzymatic defect causes an overproduction of endogenous oxalate, which is primarily excreted by the kidneys as insoluble calcium oxalate.
The condition primarily impacts the renal system across pediatric and adult populations, characteristically manifesting as recurrent nephrolithiasis and progressive nephrocalcinosis.
As renal filtration declines, progressive hyperoxalemia can precipitate systemic oxalosis, resulting in extrarenal calcium oxalate deposition throughout the skeleton, myocardium, eyes, and vasculature.
- nih.gov
Primary hyperoxaluria type I is a rare autosomal recessive metabolic disorder caused by pathogenic variants in the *AGXT* gene, leading to a deficiency of the hepatic peroxisomal enzyme alanine:glyoxylate aminotransferase
- nih.gov
Primary hyperoxaluria type I is a rare autosomal recessive metabolic disorder caused by pathogenic variants in the *AGXT* gene, leading to a deficiency of the hepatic peroxisomal enzyme alanine:glyoxylate aminotransferase This enzymatic defect causes an overproduction of endogenous oxalate, which is primarily excreted by the kidneys as insoluble calcium oxalate The condition primarily impacts the renal system across pediatric and adult populations, characteristically manifesting as recurrent nep...
Personalize your experience
Follow Primary hyperoxaluria type I and get updates as they land.
Already a member? Sign in
Follow an indication and get alerts when its drugs, labels, or guidelines change
Save any drug on this page to your favorites, synced across devices
AI-curated peer-reviewed research, summarized for your specialty
A morning digest of indication-relevant updates, when you want it
Sign in to follow this indication
Following an indication requires a free Physicians Office Resource account.